Nasus Pharma Ltd. (NSRX)

Nasus Pharma Ltd. (NSRX) is a Drug Manufacturers - General company in the Healthcare sector listed on the AMEX.

As of Oct 23, 2026: market cap $37.2M; returns 1 day +8.0%, 1 week +9.7%, 1 year -54.1%.

Nasus Pharma Ltd. is an Israeli clinical-stage biopharmaceutical company primarily focused on developing and commercializing a portfolio of powder-based intranasal (PBI) therapies for acute and life-threatening medical emergencies. The company leverages its proprietary Nasax® platform technology to create needle-free, rapidly absorbed, and stable drug formulations.

Groups NSRX belongs to

• Biotechnology
• Israel Companies
• Clinical Stage
• Clinical Stage Biopharma
• Biopharmaceutical
• Healthcare
• Israel
• Pharmaceuticals
• Life Sciences
• R&D

NSRX financial model: income statement, cash flow and balance sheet